Status:
UNKNOWN
The Community Effectiveness of IPTi in Southern Tanzania
Lead Sponsor:
Swiss Tropical & Public Health Institute
Collaborating Sponsors:
Ifakara Health Research and Development Centre
Ministry of Health, Tanzania
Conditions:
Malaria, Falciparum
Anemia
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The safety and efficacy of Intermittent Preventive Treatment for malaria and anaemia control in Infants (IPTi) have already been documented in Southern Tanzania, affording an opportunity to gain opera...
Detailed Description
A controlled trial of intermittent preventive malaria treatment in infants (IPTi) in southern Tanzania showed that treatment doses of antimalarial given to children at the time of routine vaccinations...
Eligibility Criteria
Inclusion
- child attending routine vaccination services for second or third dose of diptheria/pertussis/tetanus vaccinations (aged approximately two and three months, respectively) or for measles vaccination (aged approximately 9 months)
Exclusion
- sensitivity to sulfadoxine-pyrimethamine or other sulfur-containing drugs
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
13000 Patients enrolled
Trial Details
Trial ID
NCT00152204
Start Date
March 1 2005
End Date
December 1 2008
Last Update
May 22 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ifakara Health Research & Development Centre
Dar es Salaam, Tanzania, SLP 78373